Barely Significant
← all excerpts

The Christie hospital adjuvant tamoxifen trial--status at 10 years.

Br J Cancer · 1988 · PMC2246454 · PMID 3044432

Europe PMCDOI
2
hedged sentences
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

a marked trendP = 0.07so close (0.05 < p ≤ 0.1)
When the disease free survival of all 961 patients is analysed, allowing for node status, then there is a marked trend in favour of the TAM treated patients (P = 0.07).

also in 422 other papers

highly significantno p-value reported
l Breast 6 7 Cervix 1 2 Endometrium 1 1 Rectum 2 1 Bladder 1 2 Skin 1 1 Stomach 2 0 Ovary 1 0 Colon 1 0 Thyroid 0 1 Total 16/282=5.6% 15/306=5% Firstly, in the 6 year results of the NATO Trial of Adjuvant Tamoxifen (NATO 1985), it was shown that TAM given for two years, produced a highly significant reduction in mortality and an equally significant prolongation of the disease free interval in treated patients compared to controls (P=0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.